Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore
Viyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion animal health business. BioForLife offers a strong presence in the Italian pet care market. The acquisition is expected to finalize in the second quarter of FY 2026-27.
Viyash Scientific to acquire Milan-based pet care company BioForLife
Viyash Scientific (Viyash), through its wholly owned subsidiary Alivira Animal Health (Alivira), has signed a binding agreement to acquire 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy. The acquisition, for a cash consideration of Rs 188 crore is expected to close in Q2 FY27.
Viyash Scientific rises after subsidiary inks Rs 188-crore deal to acquire Italy's BioForLife
Viyash Scientific rose 1.59% to Rs 259.20 after the company's wholly owned subsidiary, Alivira Animal Health, has inked a binding agreement to acquire a 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy.